This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What You Should Know: – Basil Systems , a provider of an AI-powered product lifecycle intelligence platform tailored for the lifesciences industry, announced it has raised a total of $11.5M in funding led by Golden Ventures , with participation from Hearst Ventures and Argosy Capital.
Christopher McSpiritt, Head of lifesciences at Domino Data Lab Data science teams in the lifesciences industry are experiencing a significant change that will transform how clinical data is analyzed, opening the door to new possibilities for innovation. For decades, SAS was it in lifesciences.
What You Should Know: – Sware , the leading provider of comprehensive GxP validation solutions for innovative lifesciences and technology companies, today announced that it will deliver GxP computer systems validation of Salesforce LifeSciences Cloud.
What You Should Know: – venBio , a leading lifesciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments. – The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.
Source: DHL Group What You Should Know: – DHL Group has announced a significant investment of $2.2B (2B) by 2030 to strengthen its logistics capabilities in the lifesciences and healthcare sector.
Morgan Asset Management announced the establishment of a new lifesciences private equity team, LifeSciences Private Capital. – The LifeSciences Private Capital team will sit within J.P. . – The LifeSciences Private Capital team will sit within J.P. Anya Schiess.
Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals. We also worked with a large pharmaceutical company to validate the problem area and solution design." THE PROBLEM. " Sean T. Manion, ConsenSys Health. " RESULTS.
Rather, pharmacy encompasses a myriad of angles in health care – the pharmaceutical commercialization process, benefits coverage and therapy tiering, drug cost management, distribution regulations – the list could go on and on. This is where drugs come to patients and where patients see life-changing benefits of medications.
What You Should Know: – Classiq , NVIDIA , and Tel Aviv Sourasky Medical Center have established a new initiative, the Quantum Computing for LifeSciences & Healthcare Center, to develop and implement quantum algorithms and applications in these domains.
But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? Listen to our latest podcast as Malcolm Bohm, strategic advisor and board member for multiple lifesciences companies, reveals how influencer collaborations can transform brand advocacy and audience engagement.
What You Should Know: – Epic launches LifeSciences program, expanding its work to bring together the disconnected parts of healthcare. The initial focus of the LifeSciences program includes: – Matching participating providers with clinical trial opportunities suited to the makeup of their patient populations.
What You Should Know: – The index of Healthcare & LifeScience equities tracked by Stout was down 16.8% – Healthcare & LifeScience M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%
They can quickly be integrated into manufacturing lines, which means embedded RFID technologies are no longer hindering pharmaceutical manufacturing. “Manufacturers only have to use one encoding scheme for all healthcare and lifesciences customers, which should help with adoption moving forward.
While the pharmaceutical industry and lifesciences are often criticized for slow technological adoption, the metaverse presents an enormous opportunity for early adoption built on a clear understanding of value. He has 25 years of tech experience, including 16 years in the lifesciences industry.
What You Should Know: Dot Compliance , a leading provider of eQMS compliance solutions for the lifesciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for lifesciences, powered by an embedded generative and predictive artificial intelligence.
Dan UpDyke, Strategic Marketing Manager LifeSciences at Rockwell Automation. The ability to navigate constant disruption is a prerequisite for success in today’s lifescience industries. Mounting Challenges for LifeSciences Companies. million skilled jobs by 2030. .
This collaboration also introduces a transformative approach to patient marketing, particularly for pharmaceutical companies. By targeting the “invisible patient”—those undiagnosed individuals navigating complex health issues—this partnership allows companies to engage with a previously difficult-to-reach patient population.
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.
Advanced Therapy Management, to provide pharmaceutical companies with visibility into the use of patient therapies, from referrals and appointment scheduling to drug manufacturing. Digital marketplaces, which are available to pharmaceutical and medical device companies in the ecosystem to sell products and offer subscriptions.
But it’s especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data and the severity of consequences that result from data management mistakes. Best practices for managing pharmaceutical data Again, there are no simple solutions for streamlining data management in the pharmaceutical industry.
The changing landscape of the lifesciences industry relies more and more on a form of intellectual property protection called trade secrets to safeguard mechanisms of manufacturing and process knowledge not always included within lifescience patents. By Matt Bauer.
Ganesh Nathella, SVP and General Manager – Healthcare and LifeSciences (HCLS) at Persistent Systems A patient arrives at a clinic with constant chest pain. AI is revolutionizing pharmaceuticals and clinical research by significantly accelerating drug discovery and development.
However, while DTP technology could empower patients to advocate for the best possible treatment options, members of Congress and others are concerned about the potential conflict of interest for pharmaceutical companies offering direct sales. Lawmakers recently asked pharmaceutical companies questions about their tapping into virtual care.
Sujay Jadhav, CEO of Verana Health While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law , which holds that computing power would double yearly, while costs were cut in half, the lifesciences industry appears to be spending more money developing fewer drugs.
What You Should Know – Sware has secured $6 million in Series B funding to enhance its software validation solution for lifesciences companies. The Res_Q platform offers pharmaceutical, medical device, and biotechnology companies a cloud-based solution with an open API architecture.
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. This predictive capability can help pharmaceutical companies make informed decisions about whether to proceed with a trial, adjust the trial design, or even abandon a trial that is unlikely to succeed.
This investment signifies Dassault Systmes’ commitment to transforming the patient experience within the lifesciences and healthcare sectors through comprehensive, end-to-end technology solutions. This extension will foster improved coordination and outcomes among patients, physicians, caregivers, and lifescience manufacturers.
to deliver a comprehensive platform of software solutions for the lifesciences industry. Honeywell’s TrackWise Quality: Proactive Quality Management TrackWise Quality enables lifesciences companies to transition from reactive to proactive quality management by building a comprehensive quality ecosystem. ”
That is the takeaway according to a November-December 2022 survey by PhRMA of 25 large pharmaceutical manufacturers. Among respondents, it was clear the IRA price setting provisions are already impacting, and are expected to have a growing impact on, R&D plans moving forward: • 78% expect to cancel early-state pipeline projects. •
What You Should Know: – The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
Today I’m turning this post over to some of my FTI colleagues in Europe ( Antoine Mialhe , Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. A more detailed analysis is in the PDF link below.
This groundbreaking initiative seeks to advance the discovery and development of novel small molecules for drug development, sustainable crop protection, and other innovative products across a wide range of life-science industries. What You Should Know: – Evogene Ltd.
What You Should Know: – Salesforce announced the general availability of LifeSciences Cloud , a platform for pharmaceutical ( pharma ) and medical technology ( medtech ) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.
Two major pharmaceutical companies are currently beta testing it, putting them at the forefront of leveraging AI enterprise-wide to advance new medicines for patients most in need. It’s not simply the proprietary AI that’s revolutionary.
– The investment comes on the heels of a year of record growth for the company, which now counts 16 of the top 20 pharmaceutical companies as users and anticipates over 22,000 patient diagnoses daily through its Concentriq platform. We are living through an extraordinary moment in medicine, said David West, Proscias CEO.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. .”
What You Should Know: Nearly three-fourths of lifesciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Pharmaceutical leaders should consider fully incorporating this data into their workflows.
What You Should Know: – Accenture and Salesforce are investing in the development of Salesforce LifeSciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help lifesciences companies create sustainable value and drive growth.
– The enhancement connects South America and Puerto Rico more efficiently to the United States, providing crucial support for customers in the pharmaceutical and clinical research sectors navigating complex global supply chains.
What You Should Know: – The American Brain Foundation has launched a $10 million cross-disciplinary research initiative that transcends traditional research and philanthropy boundaries by bringing together nonprofit organizations, pharmaceutical and biotech investors, philanthropists, and researchers.
The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.
In 2022, the FDA released draft guidance outlining strategies for pharmaceutical companies to improve participation from underrepresented racial and ethnic groups in clinical trials. As the FDA finalizes these guidelines, pharmaceutical companies are expected to continue prioritizing investments in diversity initiatives.
Sustainable Innovation: Ecosystems, Drug Regulation, and Data Infrastructure Sustainability in lifesciences demands addressing environmental, social, and governance (ESG) challenges while navigating increasingly complex regulatory ecosystems. Norwich and Vanda Pharms. Teva Pharms. in the U.S.
Ravivrat Pandey – Associate Vice President, Indegene With its rapid adoption, 5G technology has the potential to completely revolutionize customer experiences and boost revenue in the lifescience industry. Accenture research found that companies which invest in 5G capabilities will grow revenue 2.5
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content